Chizuko Yamamoto - Concepedia

Concepedia

Author

Chizuko Yamamoto

Kansai Medical University

Also Known As

C Yamamoto, C. Yamamoto, Chizuko Yamamoto, Chizuko yamamoto

109

Publications

1.3K

Citations

21

H-Index

100

Concepts

All Affiliations

Kansai Medical University Wakayama Medical University Seiko Holdings (Japan)The University of Osaka Niigata University of Pharmacy and Medical and Life Sciences

CY

About

Chizuko Yamamoto is an author at Kansai Medical University specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	15	465
2	Social Sciences	4	4	100
3	Health Sciences	3	3	100
4	Business	1	1	11
5	Public Health	1	1	11

Chizuko Yamamoto

×

35

Publications

1.3K

Citations

21

H-Index

	Year	Citations
Loss of PTEN Expression by Blocking Nuclear Translocation of EGR1 in Gefitinib-Resistant Lung Cancer Cells Harboring Epidermal Growth Factor Receptor–Activating Mutations Chizuko Yamamoto, Yuji Basaki, Akihiko Kawahara, Cancer Research	2010	152
Molecular Diagnosis of Activating EGFR Mutations in Non–Small Cell Lung Cancer Using Mutation-Specific Antibodies for Immunohistochemical Analysis Akihiko Kawahara, Chizuko Yamamoto, Kazutaka Nakashima, Clinical Cancer Research	2010	114
Cycloprodigiosin hydrochloride, a new H+/Cl− symporter, induces apoptosis in human and rat hepatocellular cancer cell lines in vitro and inhibits the growth of hepatocellular carcinoma xenografts in nude mice Chizuko Yamamoto, Hiroto Takemoto, Kenji Kuno, Hepatology	1999	112
Involvement of specific orexigenic neuropeptides in sweetener-induced overconsumption in rats Yuichi Furudono, Chiho Ando, Chizuko Yamamoto, Behavioural Brain Research NeuropeptidesMedicinePhysiologyNeuropeptide ReceptorToxicology	2006	83
Negative Relationship Between Morphine Analgesia and P-Glycoprotein Expression Levels in the Brain Wakako Hamabe, Takehiko Maeda, Norikazu Kiguchi, Journal of Pharmacological Sciences	2007	70
A phase II study of trastuzumab and capecitabine for patients with HER2-overexpressing metastatic breast cancer: Japan Breast Cancer Research Network (JBCRN) 00 Trial Daigo Yamamoto, Satoru Iwase, Kaoru Kitamura, Cancer Chemotherapy and Pharmacology Breast OncologyOncologyPathologyPhase Ii StudyBreast Cancer	2007	57
Cycloprodigiosin hydrochloride, a H + /Cl − symporter, induces apoptosis in human breast cancer cell lines Daigo Yamamoto, Yasuhiko Kiyozuka, Yoshiko Uemura, Journal of Cancer Research and Clinical Oncology Breast OncologyEndocrine-related CancerMedicineApoptosisPharmacology	2000	55
Cycloprodigiosin hydrochloride, H+/CL- symporter, induces apoptosis and differentiation in HL-60 cells Daigo Yamamoto, Yoshiko Uemura, Kanji Tanaka, International Journal of Cancer Chemoprevention StrategyApoptosisImmunologyCell DeathCell Proliferation	2000	53
Pharmacokinetic evidence for the long-lasting effect of nor-binaltorphimine, a potent kappa opioid receptor antagonist, in mice Shiroh Kishioka, Norikazu Kiguchi, Yuka Kobayashi, Neuroscience Letters Substance AbuseLong-lasting EffectAddictionMedicinePhysiology	2013	40
Modulation of stretch reflex by anticipation of the stimulus through visual information Chizuko Yamamoto, Tomotada Ohtsuki Experimental Brain Research Stretch ReflexCognitive ScienceSensorimotor TransformationVisual FunctionEye Tracking	1989	36

Page 1